Literature DB >> 12549978

Differential effects of hyperphosphorylation on splicing factor SRp55.

Ming-Chih Lai1, Ru-Inn Lin, Woan-Yuh Tarn.   

Abstract

Members of the serine/arginine-rich (SR) protein family play an important role in both constitutive and regulated splicing of precursor mRNAs. Phosphorylation of the arginine/serine dipeptide-rich domain (RS domain) can modulate the activity and the subcellular localization of SR proteins. However, whether the SR protein family members are individually regulated and how this is achieved remain unclear. In this report we show that 5,6-dichloro-1 beta-D-ribofuranosyl-benzimidazole (DRB), an inhibitor of RNA polymerase II-dependent transcription, specifically induced hyperphosphorylation of SRp55 but not that of any other SR proteins tested. Hyperphosphorylation of SRp55 occurs at the RS domain and appears to require the RNA-binding activity. Upon DRB treatment, hyperphosphorylated SRp55 relocates to enlarged nuclear speckles. Intriguingly, SRp55 is specifically targeted for degradation by the proteasome upon overexpression of the SR protein kinase Clk/Sty. Although a destabilization signal is mapped within the C-terminal 43-amino acid segment of SRp55, its adjacent lysine/serine-rich RS domain is nevertheless critical for the Clk/Sty-mediated degradation. We report for the first time that SRp55 can be hyperphosphorylated under different circumstances whereby its fate is differentially influenced.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12549978      PMCID: PMC1223332          DOI: 10.1042/BJ20021827

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  Splicing factors SRp20 and 9G8 promote the nucleocytoplasmic export of mRNA.

Authors:  Y Huang; J A Steitz
Journal:  Mol Cell       Date:  2001-04       Impact factor: 17.970

2.  The SR protein SRp38 represses splicing in M phase cells.

Authors:  Chanseok Shin; James L Manley
Journal:  Cell       Date:  2002-11-01       Impact factor: 41.582

3.  "Stemness": transcriptional profiling of embryonic and adult stem cells.

Authors:  Miguel Ramalho-Santos; Soonsang Yoon; Yumi Matsuzaki; Richard C Mulligan; Douglas A Melton
Journal:  Science       Date:  2002-09-12       Impact factor: 47.728

4.  SR proteins: a conserved family of pre-mRNA splicing factors.

Authors:  A M Zahler; W S Lane; J A Stolk; M B Roth
Journal:  Genes Dev       Date:  1992-05       Impact factor: 11.361

5.  De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1.

Authors:  Charles E Chalfant; Kristin Rathman; Ryan L Pinkerman; Rachel E Wood; Lina M Obeid; Besim Ogretmen; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2002-01-18       Impact factor: 5.157

6.  Thiophosphorylation of U1-70K protein inhibits pre-mRNA splicing.

Authors:  J Tazi; U Kornstädt; F Rossi; P Jeanteur; G Cathala; C Brunel; R Lührmann
Journal:  Nature       Date:  1993-05-20       Impact factor: 49.962

7.  Regulation of SR protein localization during development.

Authors:  J R Sanford; J P Bruzik
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

8.  Stability of a PKCI-1-related mRNA is controlled by the splicing factor ASF/SF2: a novel function for SR proteins.

Authors:  Raphael Lemaire; Jayendra Prasad; Tsuyoshi Kashima; Jennifer Gustafson; James L Manley; Robert Lafyatis
Journal:  Genes Dev       Date:  2002-03-01       Impact factor: 11.361

9.  Casein kinase type II is involved in the inhibition by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole of specific RNA polymerase II transcription.

Authors:  R Zandomeni; M C Zandomeni; D Shugar; R Weinmann
Journal:  J Biol Chem       Date:  1986-03-05       Impact factor: 5.157

10.  Fluorescent labeling of nascent RNA reveals transcription by RNA polymerase II in domains scattered throughout the nucleus.

Authors:  D G Wansink; W Schul; I van der Kraan; B van Steensel; R van Driel; L de Jong
Journal:  J Cell Biol       Date:  1993-07       Impact factor: 10.539

View more
  18 in total

1.  RNA polymerase II carboxy-terminal domain phosphorylation is required for cotranscriptional pre-mRNA splicing and 3'-end formation.

Authors:  Gregory Bird; Diego A R Zorio; David L Bentley
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

2.  DDX3 regulates cell growth through translational control of cyclin E1.

Authors:  Ming-Chih Lai; Wen-Cheng Chang; Sheau-Yann Shieh; Woan-Yuh Tarn
Journal:  Mol Cell Biol       Date:  2010-09-13       Impact factor: 4.272

3.  Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin.

Authors:  Valerie Edmond; Elodie Moysan; Saadi Khochbin; Patrick Matthias; Christian Brambilla; Elisabeth Brambilla; Sylvie Gazzeri; Beatrice Eymin
Journal:  EMBO J       Date:  2010-12-14       Impact factor: 11.598

4.  Regulation of SR protein phosphorylation and alternative splicing by modulating kinetic interactions of SRPK1 with molecular chaperones.

Authors:  Xiang-Yang Zhong; Jian-Hua Ding; Joseph A Adams; Gourisankar Ghosh; Xiang-Dong Fu
Journal:  Genes Dev       Date:  2009-02-15       Impact factor: 11.361

5.  Akt2 regulation of Cdc2-like kinases (Clk/Sty), serine/arginine-rich (SR) protein phosphorylation, and insulin-induced alternative splicing of PKCbetaII messenger ribonucleic acid.

Authors:  Kun Jiang; Niketa A Patel; James E Watson; Hercules Apostolatos; Eden Kleiman; Olivia Hanson; Masatoshi Hagiwara; Denise R Cooper
Journal:  Endocrinology       Date:  2008-12-30       Impact factor: 4.736

Review 6.  Therapeutic targeting of splicing in cancer.

Authors:  Stanley Chun-Wei Lee; Omar Abdel-Wahab
Journal:  Nat Med       Date:  2016-09-07       Impact factor: 53.440

Review 7.  Exploiting differential RNA splicing patterns: a potential new group of therapeutic targets in cancer.

Authors:  Nidhi Jyotsana; Michael Heuser
Journal:  Expert Opin Ther Targets       Date:  2017-12-20       Impact factor: 6.902

Review 8.  VEGF gene alternative splicing: pro- and anti-angiogenic isoforms in cancer.

Authors:  P M Biselli-Chicote; A R C P Oliveira; E C Pavarino; E M Goloni-Bertollo
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-02       Impact factor: 4.553

9.  Control of alternative splicing by signal-dependent degradation of splicing-regulatory proteins.

Authors:  Rebeccah J Katzenberger; Matthew S Marengo; David A Wassarman
Journal:  J Biol Chem       Date:  2009-02-13       Impact factor: 5.157

10.  Protein kinase C-dependent control of Bcl-x alternative splicing.

Authors:  Timothée Revil; Johanne Toutant; Lulzim Shkreta; Daniel Garneau; Philippe Cloutier; Benoit Chabot
Journal:  Mol Cell Biol       Date:  2007-10-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.